FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149205972> ?p ?o ?g. }

• W2149205972 endingPage "4293" @default.
• W2149205972 startingPage "4279" @default.
• W2149205972 abstract "Combinations of anticancer therapies with high efficacy and low toxicities are highly sought after. Therefore, we studied the effect of polo-like kinase 1 (Plk1) inhibitors on prostate cancer cells as a single agent and in combination with histone deacetylase (HDAC) inhibitors valproic acid and vorinostat. IC50s of Plk1 inhibitors BI 2536 and BI 6727 were determined in prostate cancer cells by MTS assays. Morphological and molecular changes were assessed by immunoblotting, immunofluorescence, flow cytometry, real-time RT-PCR, and pulldown assays. Efficacy of combination therapy was assessed by MTS and clonogenic assays. IC50 values in DU145, LNCaP, and PC3 cells were 50, 75, and 175 nM, respectively, for BI 2536 and 2.5, 5, and 600 nM, respectively, for BI 6727. Human prostate fibroblasts and normal prostate epithelial cells were unaffected at these concentrations. While DU145 and LNCaP cells were solely arrested in mitosis on treatment, PC3 cells accumulated in G2 phase and mitosis, suggesting a weak spindle assembly checkpoint. Combining Plk1 inhibitors with HDAC inhibitors had synergistic antitumor effects in vitro. DMSO-treated prostate cancer cells were used as controls to study the effect of Plk1 and HDAC inhibition. Plk1 inhibitors decreased proliferation and clonogenic potential of prostate cancer cells. Hence, Plk1 may serve as an important molecular target for inhibiting prostate cancer. Combining HDAC inhibitors with BI 2536 or BI 6727 may be an effective treatment strategy against prostate cancer." @default.
• W2149205972 created "2016-06-24" @default.
• W2149205972 creator A5001783218 @default.
• W2149205972 creator A5009131622 @default.
• W2149205972 creator A5021406465 @default.
• W2149205972 creator A5026672223 @default.
• W2149205972 creator A5046617337 @default.
• W2149205972 creator A5060348071 @default.
• W2149205972 creator A5064010474 @default.
• W2149205972 creator A5064243944 @default.
• W2149205972 creator A5073175764 @default.
• W2149205972 creator A5081913427 @default.
• W2149205972 date "2013-07-24" @default.
• W2149205972 modified "2023-10-16" @default.
• W2149205972 title "Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors" @default.
• W2149205972 cites W120676909 @default.
• W2149205972 cites W1963837467 @default.
• W2149205972 cites W1965942138 @default.
• W2149205972 cites W1968438075 @default.
• W2149205972 cites W1971546940 @default.
• W2149205972 cites W1971909806 @default.
• W2149205972 cites W1973908775 @default.
• W2149205972 cites W1980626135 @default.
• W2149205972 cites W1981433220 @default.
• W2149205972 cites W1990532502 @default.
• W2149205972 cites W1993941887 @default.
• W2149205972 cites W1994488152 @default.
• W2149205972 cites W2020192316 @default.
• W2149205972 cites W2021336231 @default.
• W2149205972 cites W2023678160 @default.
• W2149205972 cites W2029192858 @default.
• W2149205972 cites W2059072630 @default.
• W2149205972 cites W2066264051 @default.
• W2149205972 cites W2071888464 @default.
• W2149205972 cites W2073999186 @default.
• W2149205972 cites W2077945404 @default.
• W2149205972 cites W2084478721 @default.
• W2149205972 cites W2090131485 @default.
• W2149205972 cites W2093003148 @default.
• W2149205972 cites W2093007482 @default.
• W2149205972 cites W2103789449 @default.
• W2149205972 cites W2112701137 @default.
• W2149205972 cites W2113182324 @default.
• W2149205972 cites W2114135705 @default.
• W2149205972 cites W2116068077 @default.
• W2149205972 cites W2118729083 @default.
• W2149205972 cites W2129447854 @default.
• W2149205972 cites W2147960762 @default.
• W2149205972 cites W2148566969 @default.
• W2149205972 cites W2158794909 @default.
• W2149205972 cites W2167118090 @default.
• W2149205972 cites W2167831982 @default.
• W2149205972 cites W2168282983 @default.
• W2149205972 cites W2222638000 @default.
• W2149205972 cites W2242665894 @default.
• W2149205972 cites W2244641473 @default.
• W2149205972 cites W2315405912 @default.
• W2149205972 cites W2315745650 @default.
• W2149205972 cites W823948869 @default.
• W2149205972 doi "https://doi.org/10.1096/fj.12-222893" @default.
• W2149205972 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4046181" @default.
• W2149205972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23884428" @default.
• W2149205972 hasPublicationYear "2013" @default.
• W2149205972 type Work @default.
• W2149205972 sameAs 2149205972 @default.
• W2149205972 citedByCount "26" @default.
• W2149205972 countsByYear W21492059722014 @default.
• W2149205972 countsByYear W21492059722015 @default.
• W2149205972 countsByYear W21492059722016 @default.
• W2149205972 countsByYear W21492059722017 @default.
• W2149205972 countsByYear W21492059722018 @default.
• W2149205972 countsByYear W21492059722019 @default.
• W2149205972 countsByYear W21492059722021 @default.
• W2149205972 countsByYear W21492059722022 @default.
• W2149205972 crossrefType "journal-article" @default.
• W2149205972 hasAuthorship W2149205972A5001783218 @default.
• W2149205972 hasAuthorship W2149205972A5009131622 @default.
• W2149205972 hasAuthorship W2149205972A5021406465 @default.
• W2149205972 hasAuthorship W2149205972A5026672223 @default.
• W2149205972 hasAuthorship W2149205972A5046617337 @default.
• W2149205972 hasAuthorship W2149205972A5060348071 @default.
• W2149205972 hasAuthorship W2149205972A5064010474 @default.
• W2149205972 hasAuthorship W2149205972A5064243944 @default.
• W2149205972 hasAuthorship W2149205972A5073175764 @default.
• W2149205972 hasAuthorship W2149205972A5081913427 @default.
• W2149205972 hasBestOaLocation W21492059722 @default.
• W2149205972 hasConcept C104317684 @default.
• W2149205972 hasConcept C117262875 @default.
• W2149205972 hasConcept C121608353 @default.
• W2149205972 hasConcept C126322002 @default.
• W2149205972 hasConcept C146276462 @default.
• W2149205972 hasConcept C1491633281 @default.
• W2149205972 hasConcept C185592680 @default.
• W2149205972 hasConcept C2776262904 @default.
• W2149205972 hasConcept C2776438761 @default.
• W2149205972 hasConcept C2778305200 @default.
• W2149205972 hasConcept C2779723316 @default.
• W2149205972 hasConcept C2780192828 @default.

• next